Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
11,819 results
- Lenalidomide Intensification in Patients With Serologic/Asymptomatic Progression of Multiple Myeloma While on Lenalidomide Maintenance: Complete Statistical AnalysisIndependent statistical analysis of Lenalidomide Intensification in Patients With Serologic/Asymptomatic Progression of Multiple Myeloma While on Lenalidomide Maintenance: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- LENSIndependent statistical analysis of Lowering Events in Non-proliferative Retinopathy in Scotland: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03439345).
- Lentiviral (LV) Gene Therapy for Adenosine Deaminase (ADA) Deficiency: Complete Statistical AnalysisIndependent statistical analysis of Lentiviral (LV) Gene Therapy for Adenosine Deaminase (ADA) Deficiency: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01380990).
- LEO 90100 Compared to Vehicle in Subjects With Psoriasis Vulgaris: Complete Statistical AnalysisIndependent statistical analysis of LEO 90100 Compared to Vehicle in Subjects With Psoriasis Vulgaris: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01866163).
- LEO 90100 Compared With Calcipotriol Plus Betamethasone Dipropionate Ointment, LEO 90100 Vehicle and Ointment Vehicle in Subjects With Psoriasis Vulgaris: Complete Statistical AnalysisIndependent statistical analysis of LEO 90100 Compared With Calcipotriol Plus Betamethasone Dipropionate Ointment, LEO 90100 Vehicle and Ointment Vehicle in Subjects With Psoriasis Vulgaris: primary endpoint results, effect estimate with confidence interval,…
- LESS TEP vs. Three Port TEP for Inguinal Hernia Repair: Complete Statistical AnalysisIndependent statistical analysis of LESS TEP vs. Three Port TEP for Inguinal Hernia Repair: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04303182).
- Letermovir (MK-8228) Versus Placebo in the Prevention of Clinically-Significant Cytomegalovirus (CMV) Infection in Adult, CMV-Seropositive Allogeneic Hematopoietic Stem Cell Transplant Recipients (MK-8228-001): Complete Statistical AnalysisIndependent statistical analysis of Letermovir (MK-8228) Versus Placebo in the Prevention of Clinically-Significant Cytomegalovirus (CMV) Infection in Adult, CMV-Seropositive Allogeneic Hematopoietic Stem Cell Transplant Recipients (MK-8228-001): primary endpoint results, effect estimate with…
- LETISIndependent statistical analysis of Assessing the Effect of Lettuce on Intestinal Water Content Through Magnetic Resonance Imaging of the Small Bowel: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Letrozole in Breast Cancer Who Have Received 5 Years of Aromatase Inhibitor Therapy: Complete Statistical AnalysisIndependent statistical analysis of Letrozole in Breast Cancer Who Have Received 5 Years of Aromatase Inhibitor Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Leucine for Depression Study (L-DEP): Complete Statistical AnalysisIndependent statistical analysis of Leucine for Depression Study (L-DEP): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03557684).
- LEUKOIndependent statistical analysis of Zileuton to Treat Adults With Chronic Obstructive Pulmonary Disease (The LEUKO Study): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Leuprolide Acetate or Goserelin Acetate With or Without Vismodegib Followed by Surgery in Treating Patients With Locally Advanced Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Leuprolide Acetate or Goserelin Acetate With or Without Vismodegib Followed by Surgery in Treating Patients With Locally Advanced Prostate Cancer: primary endpoint results, effect estimate with confidence interval,…
- LEVANT 2 Safety Registry: Complete Statistical AnalysisIndependent statistical analysis of LEVANT 2 Safety Registry: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01790243).
- Levetiracetam 1000 mg Under Non-Fasting Conditions: Complete Statistical AnalysisIndependent statistical analysis of Levetiracetam 1000 mg Under Non-Fasting Conditions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00859430).
- Levetiracetam 750 mg Tablets Under Fasting Conditions: Complete Statistical AnalysisIndependent statistical analysis of Levetiracetam 750 mg Tablets Under Fasting Conditions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00849862).
- Levetiracetam for the Treatment of Alcohol Dependence and Anxiety: Complete Statistical AnalysisIndependent statistical analysis of Levetiracetam for the Treatment of Alcohol Dependence and Anxiety: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00141115).
- Levetiracetam in the Management of Bipolar Depression: Complete Statistical AnalysisIndependent statistical analysis of Levetiracetam in the Management of Bipolar Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00566150).
- Levetiracetam Versus Topiramate as Adjunctive Therapy to Evaluate Efficacy and Safety in Subjects With Refractory Partial Onset Seizures: Complete Statistical AnalysisIndependent statistical analysis of Levetiracetam Versus Topiramate as Adjunctive Therapy to Evaluate Efficacy and Safety in Subjects With Refractory Partial Onset Seizures: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Levetiracetam Versus Valproate in Idiopathic Generalized Tonic-clonic Seizures: Complete Statistical AnalysisIndependent statistical analysis of Levetiracetam Versus Valproate in Idiopathic Generalized Tonic-clonic Seizures: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03940326).
- levobupiIndependent statistical analysis of Spinal Anesthesia With Hyperbaric Levobupivacaine 0.75% for Ambulatory Knee Arthroscopy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01881087).
- Levocarnitine in Treating Fatigue in Cancer Patients: Complete Statistical AnalysisIndependent statistical analysis of Levocarnitine in Treating Fatigue in Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00091169).
- Levodopa and Exercise for Older Adults With Depression and Psychomotor Slowing: Complete Statistical AnalysisIndependent statistical analysis of Levodopa and Exercise for Older Adults With Depression and Psychomotor Slowing: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Levofloxacin-containing Therapies In Second Line Helicobacter Pylori Eradication: Complete Statistical AnalysisIndependent statistical analysis of Levofloxacin-containing Therapies In Second Line Helicobacter Pylori Eradication: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02596620).
- LFMSIndependent statistical analysis of LFMS: Initial Trial in Geriatric Bipolar Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02707276).
- LHONIndependent statistical analysis of Safety Study of an Adeno-associated Virus Vector for Gene Therapy of Leber's Hereditary Optic Neuropathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- LIBERATEIndependent statistical analysis of Pulmonx Endobronchial Valves Used in Treatment of Emphysema (LIBERATE Study): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01796392).
- LIBERATE – LIposomal Bupivacaine vERsus Adjuncts in Total shouldErs: Complete Statistical AnalysisIndependent statistical analysis of LIBERATE - LIposomal Bupivacaine vERsus Adjuncts in Total shouldErs: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03887650).
- LIBERTIIndependent statistical analysis of Low-dose Intra-arterial Bevacizumab for Edema and Radiation Necrosis Therapeutic Intervention (LIBERTI): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- LID in PDIndependent statistical analysis of Safety and Efficacy of AVP-923 in the Treatment of Levodopa-induced Dyskinesia in Parkinson's Disease Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Lidocaine Administration Using STAR Particles: Complete Statistical AnalysisIndependent statistical analysis of Lidocaine Administration Using STAR Particles: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06034340).
- LIDSIndependent statistical analysis of A Phase 2b, Study of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- LIFEIndependent statistical analysis of The LIFE Study - Lifestyle Interventions and Independence for Elders: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01072500).
- Life-Steps Counseling to Enhance Adherence and Engagement in PrEP Care: Complete Statistical AnalysisIndependent statistical analysis of Life-Steps Counseling to Enhance Adherence and Engagement in PrEP Care: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04316715).
- LifeFlow Fluid Study- Non- Critical Pediatric Patients Having a Trans Abdominal Ultrasound: Complete Statistical AnalysisIndependent statistical analysis of LifeFlow Fluid Study- Non- Critical Pediatric Patients Having a Trans Abdominal Ultrasound: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Lifestyle Intervention for Weight Gain Management for Patients With Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of Lifestyle Intervention for Weight Gain Management for Patients With Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01368406).
- Lifestyle Intervention in Preparation for Pregnancy (LIPP): Complete Statistical AnalysisIndependent statistical analysis of Lifestyle Intervention in Preparation for Pregnancy (LIPP): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03146156).
- Lifestyle Modification and Lorcaserin for Weight Loss Maintenance: Complete Statistical AnalysisIndependent statistical analysis of Lifestyle Modification and Lorcaserin for Weight Loss Maintenance: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02388568).
- Light Treatment to Improve Symptom Management of Fibromyalgia Syndrome: Complete Statistical AnalysisIndependent statistical analysis of Light Treatment to Improve Symptom Management of Fibromyalgia Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03794908).
- LiiRAIndependent statistical analysis of Lipids, Inflammation, and CV Risk in RA: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02714881).
- Like Father Like Son: Complete Statistical AnalysisIndependent statistical analysis of Like Father Like Son: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04119414).
- Linaclotide Safety and Efficacy in 2 to 5-Year-Old Participants With Functional Constipation: Complete Statistical AnalysisIndependent statistical analysis of Linaclotide Safety and Efficacy in 2 to 5-Year-Old Participants With Functional Constipation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Linagliptin as Add on to Basal Insulin in the Elderly: Complete Statistical AnalysisIndependent statistical analysis of Linagliptin as Add on to Basal Insulin in the Elderly: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02240680).
- Linear Energy Transfer (LET)-Optimized Intensity Modulated Proton Therapy (IMPT) as a Component of Definitive Chemoradiation for Newly Diagnosed Squamous Cell Carcinoma of the Anal Canal: a Feasibility Trial: Complete Statistical AnalysisIndependent statistical analysis of Linear Energy Transfer (LET)-Optimized Intensity Modulated Proton Therapy (IMPT) as a Component of Definitive Chemoradiation for Newly Diagnosed Squamous Cell Carcinoma of the Anal Canal: a Feasibility Trial:…
- LINK: Aftercare Monitoring Project: Complete Statistical AnalysisIndependent statistical analysis of LINK: Aftercare Monitoring Project: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00265512).
- LinkPositively: A Technology-Delivered Peer Navigation and Social Networking Intervention to Improve HIV Care: Complete Statistical AnalysisIndependent statistical analysis of LinkPositively: A Technology-Delivered Peer Navigation and Social Networking Intervention to Improve HIV Care: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Linsitinib or Topotecan Hydrochloride in Treating Patients With Relapsed Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Linsitinib or Topotecan Hydrochloride in Treating Patients With Relapsed Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- LIPIDS-PIndependent statistical analysis of LIPIDS-P Trial Phase I/II Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03405870).
- Lipopolysaccharide (LPS) or Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Challenge Study on Healthy Subjects: Complete Statistical AnalysisIndependent statistical analysis of Lipopolysaccharide (LPS) or Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Challenge Study on Healthy Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Liposomal Amikacin for Inhalation (LAI) for Nontuberculous Mycobacteria: Complete Statistical AnalysisIndependent statistical analysis of Liposomal Amikacin for Inhalation (LAI) for Nontuberculous Mycobacteria: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01315236).
- Liposomal Bupivacaine After Arthroscopic Rotator Cuff Repair: Complete Statistical AnalysisIndependent statistical analysis of Liposomal Bupivacaine After Arthroscopic Rotator Cuff Repair: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03149887).